Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
HIV/AIDS Co-Infection - Findings from M.L. Grijsen and co-researchers advance knowledge in HIV/AIDS co-infection
Gene Therapy - Reports from Merck & Company, Inc. highlight recent research in gene therapy
HIV/AIDS Immunology - New HIV/AIDS immunology study results reported from Swedish Institute for Infectious Disease Control
HIV/AIDS Vaccines - Data on HIV/AIDS vaccines described by researchers at Swedish Institute for Infectious Disease Control, Department of Virology
HIV/AIDS Vaccines - Data on HIV/AIDS vaccines published by researchers at Karolinska Institut
HIV/AIDS Vaccines - Data on HIV/AIDS vaccines reported by investigators at Research Institute for Genetic and Human Therapy
HIV/AIDS Vaccines - New findings reported from Linkoping University, Department of Molecular Virology describe advances in HIV/AIDS vaccines
HIV/AIDS Vaccines - Research on HIV/AIDS vaccines reported by scientists at Karolinska Institute
HIV/AIDS Vaccines - Researchers from Institute of Microbiology detail findings in HIV/AIDS vaccines
HIV/AIDS Vaccines - Scientists at Engelhardt Institute of Molecular Biology report research in HIV/AIDS vaccines
HIV/AIDS Vaccines - Scientists at Wyeth publish research in HIV/AIDS vaccines
HIV/AIDS Vaccines - Studies in the area of HIV/AIDS vaccines reported from Dartmouth University, Department of Microbiology & Immunology
Immunization - Scientists at Center for Cancer Research detail research in immunization
Merck & Co., Inc. - New Phase III Study in Previously Untreated HIV Patients Showed Merck's ISENTRESS raltegravir Reduced HIV Viral Load to Undetectable Levels, Comparable to Efavirenz, When Taken in Combination with Other Medicines
NewsRx - NewsRx Launches Politics & Government Titles; Offers Free Global Warming Publication
Progenics Pharmaceuticals, Inc. - Progenics Reports Positive Interim Phase 2 Results for Two Dosage Forms of Novel HIV Therapy PRO 140
